Navigation Links
Fate Therapeutics Strengthens Its iPSC Platform
Date:11/16/2011

SAN DIEGO, Nov. 16, 2011 /PRNewswire/ -- Fate Therapeutics, Inc. announced today that the United States Patent and Trademark Office has granted a patent covering the novel stem cell modulator commonly known as Thiazovivin.  U.S. Patent No. 8,044,201 entitled "Stem Cell Cultures" claims Thiazovivin, a small molecule Rho-associated kinase (ROCK) inhibitor, as well as compositions and cell culture media comprising Thiazovivin.  Thiazovivin is crucial to the efficient generation of human induced pluripotent stem cells (iPSCs), and the survival of human embryonic stem cells (hESCs), in culture.  Fate Therapeutics holds an exclusive license from The Scripps Research Institute (TSRI) to the patent in all commercial fields.

"The generation, survival and expansion of pluripotent stem cells – without compromise to their self-renewal capacity and ultimate differentiation potential – remains critical to realizing the potential of stem cell biology-based therapeutics," said Dr. John Mendlein, Executive Chairman of Fate Therapeutics.  "We believe that our industrialized iPSC product engine, including our high throughput methods of reprogramming, cell selection, characterization and single-cell passaging, offers a powerful opportunity for stem cell research and drug discovery, and for the potential development of iPSC-derived cell therapies."

The importance of Thiazovivin in enabling an industrialized iPSC product platform was first elucidated by Sheng Ding, Ph.D., a scientific founder of Fate Therapeutics, while at TSRI.  Under a research collaboration between TSRI and Fate Therapeutics, Dr. Ding and his team of TSRI scientists first demonstrated that Thiazovivin, in combination with other small molecules, dramatically improves the reprogramming of human fibroblasts by 200-fold as compared to non-chemically enhanced methods of iPSC generation (Lin, T., et al, Nature
'/>"/>

SOURCE Fate Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
2. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
3. Amsterdam Molecular Therapeutics Reports Half Year Results 2008
4. BN ImmunoTherapeutics Announces Partnership With National Cancer Institute
5. Arno Therapeutics Announces Appointment of Brian Lenz, CPA as Chief Financial Officer
6. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
7. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
8. Nile Therapeutics, Inc. Reports 2008 Second Quarter Financial Results
9. Cell Therapeutics, Inc.s Second Quarter 2008 Financial Results
10. Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug
11. Arno Therapeutics Announces Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... MA (PRWEB) December 23, 2014 ... is designed to introduce cutting edge communication technology, ... of platform upgrades. This webinar series demonstrates online ... quest to leverage web conferencing’s most innovative and ...
(Date:12/24/2014)... York (PRWEB) December 23, 2014 According to ... Long Island Affiliate of ITRA Global, the national office market ... steady recovery. This is evidenced by the third quarter’s ... stock market. Low energy costs have held inflation down ...
(Date:12/24/2014)... Nashville Fertility Center announced that Dr. George A. ... Reproductive Medicine (ASRM), a leading professional organization committed to advancing ... role as treasurer, Dr. Hill also fills a seat on ... the mission of ASRM. , Dr. Hill has actively ...
(Date:12/24/2014)... 23, 2014 Pipette.com announces their Holiday ... submit their #HolidayInTheLab pictures for a chance to win pipette-themed ... struggling to think of a holiday gift for their beloved ... the ideal holiday presents. The #HolidayInTheLab Contest encourages Pipette.com ...
Breaking Biology Technology:SoundConnect Launches Leading Edge Business Communications Webinar Series 2SoundConnect Launches Leading Edge Business Communications Webinar Series 3ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2
... Novavax, Inc. (Nasdaq: NVAX ) announced today ... company,s Chief Scientific Officer who will report to Dr. ...  Previously, Dr. Glenn was Chief Scientific Officer and founder of ... Johns Hopkins University,s School of Public Health and ...
... 2010 Olivier Bohuon will be,replacing Jean-Pierre Garnier ... , , , ... Olivier Bohuon , 51, was Executive Vice-President of the Abbott,Corporation and President ... Chicago ( $22 billion in sales).,In 2003, he was named ...
... , July 1 United Therapeutics Corporation ... (HKEx: 0950) announced today that they have entered into ... Injection in China .  Remodulin is a subcutaneously ... pulmonary arterial hypertension.  Lee,s Pharmaceutical is a leading Chinese ...
Cached Biology Technology:Novavax Announces Appointment of Dr. Gregory Glenn as Chief Scientific Officer 2Novavax Announces Appointment of Dr. Gregory Glenn as Chief Scientific Officer 3Novavax Announces Appointment of Dr. Gregory Glenn as Chief Scientific Officer 4Olivier Bohuon Joins Pierre Fabre 2United Therapeutics and Lee's Pharmaceutical Sign Remodulin Distribution Agreement for China 2United Therapeutics and Lee's Pharmaceutical Sign Remodulin Distribution Agreement for China 3United Therapeutics and Lee's Pharmaceutical Sign Remodulin Distribution Agreement for China 4United Therapeutics and Lee's Pharmaceutical Sign Remodulin Distribution Agreement for China 5
(Date:1/22/2015)... 22, 2015   EyeLock, Inc. , a market leader of ... Steve Gerber to the new role of Senior Vice ... leading development of mobile platforms and wearable solutions for EyeLock,s ... innovation in the semiconductor industry to his role at EyeLock, ...
(Date:12/22/2014)... 2014 Holiday Season may be the brightest ever for ... the long anticipated floodgates for consumer biometrics may finally ... phones, tablets, and wearable mobile devices that incorporate biometrics ... with nearly 4.8 billion biometric devices by 2020.   ...
(Date:12/17/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/s6qzt5/samsung_galaxy_s5 ) ... S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis" ... http://photos.prnewswire.com/prnh/20130307/600769 Based on a totally ... for the first time a fingerprint sensor in its ...
Breaking Biology News(10 mins):EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2
... for splitting water into hydrogen and oxygen, driven by ... today, underpinning the long term potential of hydrogen as ... today are very inefficient and often require additional use ... important to establish new mechanisms by which water splitting ...
... eaten raw, fried and baked it even produces banana beer ... the fruit is only a small percentage of what the plant ... to rot as waste. Now scientists at The University of ... fuel, developing simple methods of producing banana briquettes that could be ...
... Three-day-old broccoli sprouts, a widely available human food, suppressed ... to a report in Cancer Prevention Research , a ... H. pylori infections are one of the most common ... cancer. The cancer protective effects of sulforaphane, a ...
Cached Biology News:Weizmann Institute scientists develop a unique approach for splitting water into hydrogen and oxygen 2Weizmann Institute scientists develop a unique approach for splitting water into hydrogen and oxygen 3Going bananas for sustainable research -- scientists create fuel from African crop waste 2
... The Model 1575 immunowash microplate washer ... microplates that have flat-, U-, or V-bottom ... of horizontal and vertical needle positions to ... washing, crosswise aspiration, and overflow washing. It ...
... a compact benchtop and stackable multi-function ... with a large display screen to ... Air circulation inside to evenly distribute ... be easily calibrated from the microprocessor ...
... MULTI-FUN Incubator is a compact benchtop ... a microprocessor controller with a large ... and agitation speed. Air circulation inside ... incubator. Temperature can be easily calibrated ...
... cocktail of 3 siRNAs specifically targeted to ... popular product. The siTrio reagent guarantees you ... target gene when used under standard conditions ... of optimal transfection with one of B-Bridges ...
Biology Products: